Item Type | Name |
Concept
|
Eclampsia
|
Concept
|
Pre-Eclampsia
|
Academic Article
|
Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors.
|
Academic Article
|
Clinical characterization and outcomes of preeclampsia with normal angiogenic profile.
|
Academic Article
|
Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.
|
Academic Article
|
Preeclampsia and the risk of large-for-gestational-age infants.
|
Academic Article
|
Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study.
|
Academic Article
|
Neuropsychological performance in normal pregnancy and preeclampsia.
|
Academic Article
|
Angiogenic factors in diagnosis, management, and research in preeclampsia.
|
Academic Article
|
Circulating soluble endoglin and placental abruption.
|
Academic Article
|
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.
|
Academic Article
|
Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.
|
Academic Article
|
Circulating lymphangiogenic factors in preeclampsia.
|
Academic Article
|
Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period.
|
Academic Article
|
Adverse maternal and fetal outcomes and deaths related to preeclampsia and eclampsia in Haiti.
|
Academic Article
|
Mid-pregnancy levels of angiogenic markers as indicators of pathways to preterm delivery.
|
Academic Article
|
Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia.
|
Academic Article
|
The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome.
|
Academic Article
|
The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes.
|
Academic Article
|
Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia.
|
Academic Article
|
Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis.
|
Academic Article
|
Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1.
|
Academic Article
|
Role of oxidative stress and antioxidant supplementation in pregnancy disorders.
|
Academic Article
|
Response to Carbillon L et al. letter titled; "The imbalance of circulating angiogenic/anti-angiogenic factors is mild or absent in obese women destined to develop preeclampsia".
|
Academic Article
|
Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes.
|
Academic Article
|
Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia.
|
Academic Article
|
First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia.
|
Academic Article
|
Angiogenic factors in preeclampsia: potential for diagnosis and treatment.
|
Academic Article
|
Angiogenic factors and pregnant woman with new onset seizures.
|
Academic Article
|
Preeclampsia: the role of angiogenic factors in its pathogenesis.
|
Academic Article
|
Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.
|
Academic Article
|
Placental origins of angiogenic dysfunction in mirror syndrome.
|
Academic Article
|
Physicians' knowledge of future vascular disease in women with preeclampsia.
|
Academic Article
|
Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia.
|
Academic Article
|
Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia.
|
Academic Article
|
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.
|
Academic Article
|
Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
|
Academic Article
|
Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy.
|
Academic Article
|
Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
|
Academic Article
|
KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
|
Academic Article
|
Racial Disparities in Comorbidities, Complications, and Maternal and Fetal Outcomes in Women With Preeclampsia/eclampsia.
|
Academic Article
|
Gelsolin is an endogenous inhibitor of syncytiotrophoblast extracellular vesicle shedding in pregnancy.
|
Academic Article
|
Trophoblast mitochondrial function is impaired in preeclampsia and correlates negatively with the expression of soluble fms-like tyrosine kinase 1.
|
Academic Article
|
Angiogenic Proteins: Can These Biomarkers Help to Prevent Maternal Deaths Related to Preeclampsia?
|
Academic Article
|
Abnormal mid-trimester cardiac strain in women with chronic hypertension predates superimposed preeclampsia.
|
Academic Article
|
Analytical validation of soluble fms-like tyrosine and placental growth factor assays on B·R·A·H·M·S KRYPTOR Compact Plus automated immunoassay platform.
|
Academic Article
|
Angiogenic biomarkers in triage and risk for preeclampsia with severe features.
|
Academic Article
|
Association of antepartum blood pressure levels and angiogenic profile among women with chronic hypertension.
|
Academic Article
|
Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized Patients.
|
Academic Article
|
Preeclampsia: Pathophysiology, Challenges, and Perspectives
|
Academic Article
|
Antepartum Aspirin Administration Reduces Activin A and Cardiac Global Longitudinal Strain in Preeclamptic Women.
|
Academic Article
|
Evaluation of angiogenic factors in the decision to admit women with suspected preeclampsia.
|
Academic Article
|
Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.
|
Academic Article
|
Luteolin-induced vasorelaxation in uterine arteries from normal pregnant rats.
|
Academic Article
|
Real life outpatient biomarker use in management of hypertensive pregnancies in third trimester in a low resource SeTting: ROBUST study.
|
Academic Article
|
Long-Term Postpartum Cardiac Function and Its Association With Preeclampsia.
|
Academic Article
|
The interval between births and the risk of recurrent preeclampsia among predominantly high risk women in urban tertiary care center.
|
Academic Article
|
Angiogenic factors and prediction for ischemic placental disease in future pregnancies.
|
Academic Article
|
Is Prolonging Gestation in Preeclampsia For Better or Worse in Preventing Cardiovascular Disease?
|
Academic Article
|
Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia.
|
Academic Article
|
Prevalence and management of severe intrapartum hypertension in patients with preeclampsia at an urban tertiary care medical center.
|
Academic Article
|
The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice.
|
Academic Article
|
Racial Disparities in Diagnosis, Management, and Outcomes in Preeclampsia.
|
Academic Article
|
Women's perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia.
|
Academic Article
|
Racial Differences in Readmissions in Hypertensive Disorders of Pregnancy.
|
Academic Article
|
Association of fetal sex with angiogenic factors in normotensive and hypertensive pregnancy states.
|
Academic Article
|
The additive role of angiogenic markers for women with confirmed preeclampsia.
|
Academic Article
|
Reducing the Risk of Term Preeclampsia by Risk-Stratified Timing of Birth: Time to Deliver.
|
Academic Article
|
Bioflavonoid luteolin prevents sFlt-1 release via HIF-1a inhibition in cultured human placenta.
|
Academic Article
|
Patient and provider perception of home blood pressure monitoring kits.
|
Academic Article
|
Association of activin A and postpartum blood pressure in peripartum cardiomyopathy.
|
Academic Article
|
Luteolin prevents TNF-a-induced NF-?B activation and ROS production in cultured human placental explants and endothelial cells.
|
Academic Article
|
Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy.
|